Cargando…
Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model
INTRODUCTION: There is increasing scientific evidence to substantiate using low‐dose glucagon as a supplement to insulin therapy in artificial pancreata for diabetes mellitus type 1. The delivery of both these hormones intraperitoneally would mimic normal physiology. However, our knowledge of the ph...
Autores principales: | Teigen, Ingrid Anna, Åm, Marte Kierulf, Carlsen, Sven Magnus, Christiansen, Sverre Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321685/ https://www.ncbi.nlm.nih.gov/pubmed/35416407 http://dx.doi.org/10.1111/bcpt.13731 |
Ejemplares similares
-
Pharmacokinetics of Intraperitoneally Delivered Glucagon in Pigs: A Hypothesis of First Pass Metabolism
por: Teigen, Ingrid Anna, et al.
Publicado: (2021) -
Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels
por: Åm, Marte Kierulf, et al.
Publicado: (2020) -
Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2018) -
Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices
por: Teigen, Ingrid Anna, et al.
Publicado: (2022) -
Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2021)